• Log Out Log In
  • T. Rowe Price Health Sciences Fund (PRHSX)
    Ticker Symbol:
    Fund Status:
    Open to new Retail investors  /  Open to subsequent Retail investments
    Fund Composition
    Asset Allocation
    as of 06/30/2014
    Volatility and Other Measures
    as of 08/31/2014
    Beta 0.88
    Standard Deviation 14.27
    Price/Earnings Ratio (Domestic) 20.6
    Earnings Growth Rate (Domestic) 14.3
    Turnover Rate 33.8
    Median Market
    $22,477.42 Million
    10 Largest Holdings
    Represents 34.36 % of Total Net Assets
    View Holdings as of:
    Actavis plc
    Alexion Pharmaceuticals
    Allergan Inc/United States
    Biogen Idec
    Gilead Sciences
    Puma Biotechnology
    UnitedHealth Group
    Valeant Pharmaceuticals International
    As of 09/30/2014 the Health Sciences Fund had a total of 154 holdings.
    Sector Diversification
    as of 08/31/2014
    % of Total Net Assets
    Biotechnology 34.4%
    Services 24.7%
    Pharmaceuticals 21.1%
    Products & Devices 10.8%
    Life Sciences 5.2%
    Miscellaneous 2.7%
    See Glossary for additional details on all data elements.